volume 1, issue 3, P100145 2020
DOI: 10.1016/j.xpro.2020.100145
View full text
Sign up to set email alerts

Abstract: Summary Studying circulating cell-free DNA (cfDNA) release within preclinical model systems provides opportunities to investigate the mechanisms and kinetics underlying this process under various conditions. We present a detailed protocol for longitudinal evaluation of cfDNA release through (1) seeding of cancer cell lines and establishment of xenograft tumors, (2) treatment of cancer cells and xenograft tumors, (3) serial collection of cell line media and xenograft blood, and (4) processing and iso…

Expand abstract